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Photosystem II (PSII) catalyzes the light-driven oxidation of water
and the reduction of plastoquinone; the oxidation of water occurs
at a cluster of four manganese. The PSII CP43 subunit functions in
light harvesting, and mutations in the fifth luminal loop (E) of CP43
have established its importance in PSII structure andor assembly
[Kuhn, M. G. & Vermaas, V. F. J. (1993) Plant Mol. Biol. 23, 123–133].
The sequence A350PWLEPLR357 in luminal loop E is conserved in
CP43 genes from 50 organisms. To map important posttranslational
modifications in this sequence, tandem mass spectrometry (MS
MS) was used. These data show that the indole side chain of
Trp-352 is posttranslationally modified to give mass shifts of 4,
16, and 18 daltons. The masses of the modifications suggest
that the tryptophan is modified to kynurenine (4), a keto-
amino-hydroxy- (16) derivative, and a dihydro-hydroxy- (18)
derivative of the indole side chain. Peptide synthesis and MSMS
confirmed the kynurenine assignment. The 16 and 18 trypto-
phan modifications may be intermediates formed during the oxi-
dative cleavage of the indole ring to give kynurenine. The site-
directed mutations, W352C, W352L, and W352A, exhibit an
increased rate of photoinhibition relative to wild type. We hypoth-
esize that Trp-352 oxidative modifications are a byproduct of PSII
water-splitting or electron transfer reactions and that these mod-
ifications target PSII for turnover. As a step toward understanding
the tertiary structure of this CP43 peptide, structural modeling was
performed by using molecular dynamics.
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Photosystem II (PSII) is a protein–pigment complex located inthylakoid membranes of plants, eukaryotic algae, and cya-
nobacteria. PSII catalyzes the light-driven oxidation of water to
O2, and the reduction of plastoquinone. PSII contains both
intrinsic and extrinsic polypeptides. The intrinsic polypeptides
include chlorophyll-binding proteins, CP47, CP43, and the D1
and D2 polypeptides (reviewed in ref. 1). The D2D1 het-
erodimer binds P680, pheophytin, and the quinone receptors, QA
and QB (2). Three extrinsic subunits, the manganese stabilizing,
24-kDa, and 18-kDa proteins, are required for maximum oxygen
evolution in plants (3, 4). Recently, a 3.8-Å structure of the
cyanobacterial PSII reaction center has been reported (5, 6).
The intrinsic PSII subunits, CP43 and CP47, function as
light-harvesting proteins and play a role in PSII assembly and
activity (7–11). CP47 and CP43 have similar tertiary and sec-
ondary structures (5). Each polypeptide has six membrane-
spanning regions and a large luminal, hydrophilic loop (E)
between helix V and VI (5, 7). In Synechocystis sp. PCC 6803,
loop E of the CP43 subunit extends from residue Asn-280 to
Trp-412 (9). Mutations or deletions in this loop inactivate or
impair PSII activity in Synechocystis (9, 11–13).
Posttranslational modifications can play important roles in the
assembly, degradation, structure, and function of proteins. How-
ever, little is known about the roles of such modifications in
membrane proteins. For example, in cytochrome c oxidase, a
crosslinked tyrosine–histidine cofactor has been identified at the
binuclear metal site (14); the function of this cofactor has not yet
been definitively established. Recently, it has been suggested
that posttranslationally modified amino acids, containing car-
bonyl groups, covalently bind hydrazines and amines at the
catalytic site of PSII (10, 15). Because amines and hydrazines are
inhibitors of photosynthetic water oxidation, it was suggested
that these carbonyl-containing amino acids play roles in the
structure, function, or assembly of PSII.
To obtain more information about posttranslational modifi-
cations in PSII, we have used tandem mass spectrometry (MS
MS; ref. 16). MSMS has been used previously to obtain
structural information about intrinsic membrane proteins (for
examples, see refs. 17–20). MS is one of the few techniques that
can detect altered amino acid side chains in membrane proteins,
which are difficult to study by other high resolution structural
techniques. Previously, MS has detected stable oxidation prod-
ucts of D1D2 in a PSII reaction center preparation (21).
Electrospray ionization MS data have also suggested posttrans-
lational modifications in CP47 and CP43 (18).
In this study, we report that a tryptophan in a highly conserved
region of CP43 is posttranslationally modified. As assessed by the
observed mass-to-charge ratios, multiple types of tryptophan
modifications are present. We hypothesize that these modifica-
tions play a role in signaling the turnover of the PSII reaction
center.
Materials and Methods
Reagents. 14C-phenylhydrazine (specific activity, 2.65 mCi
mmol; 1 Ci 37 GBq) was obtained from California Bionuclear
Corporation (Los Angeles). 2-Br-phenylhydrazine was pur-
chased from Aldrich, and sequencing-grade trypsin was pur-
chased from Promega.
Sample Preparation. PSII was isolated from market spinach (22)
with the modifications described (15). PSII samples were main-
tained under dim light (0.6–16 E m2s1). Chlorophyll and
oxygen assays were performed (23, 24). Steady-state rates of
oxygen evolution were 700 mol O2 (mg of chl)1h1. PSII
membranes were Tris-washed, generating PSII-3 and removing
the manganese cluster and extrinsic subunits (15).
In Situ Trypsin Digests. In situ trypsin digestion of spinach PSII was
performed by a previously described procedure (20). Briefly, 1.1
nmol of oxygen evolving PSII or PSII-3 was illuminated (3620E
s1m2) or incubated in the dark for 30 min. The buffer was 50
mM Hepes–NaOH, pH 7.5. Illumination was from a Dolan–
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Jenner annular illuminator equipped with a red filter and a heat
filter. The membranes were then precipitated with 95% ethanol.
After resuspending pellets in 4 M urea, trypsin digestion (12.5
ngl) was performed for 17–25 h at 37°C in a buffer containing
50 mM NH4HCO3 and 5 mM CaCl2. The dried samples were
resuspended in 0.5% formic acid or 0.2% acetic acid before
MSMS analysis.
In Gel Trypsin Digests. PSII-3 samples (35 nmol) were incubated
with 56 M 14C- or 12C-phenylhydrazine, 56 M 2-Br-
phenylhydrazine, or no phenylhydrazine under room light for 30
min in buffer containing 50 mM Hepes–NaOH, pH 7.552 mM
Na2CO32.6 M urea2% SDS (15). Samples were subjected to
SDSPAGE, and the portion of the gel, containing CP43 and
CP47, was excised (20).
For in gel digestion, the gel blocks were rehydrated at room
temperature with a solution containing 50 mM NH4HCO3, 5 mM
CaCl2, 12.5 ngl trypsin and incubated at 37°C. The peptides
were extracted from the gel pieces, as described (20), except that
0.3% TEAA (triethylammonium acetate), pH 7.0, and acetoni-
trile were used in a 1:1 ratio. The peptide solution was concen-
trated with argon or dried in vacuo.
In gel digested samples were filtered and injected onto a
phenyl S 5-m, 300-Å, 3.0  250-mm column (Waters), which
had been equilibrated with 0.3% TEAA, pH.7.0 (solvent A), on
an HPLC system (Beckman Coulter). Peptides were eluted with
buffer B, containing 0.3% TEAA, pH 7.0, and 90% acetonitrile;
elution of peptides was monitored at 214 nm. The fraction used
for these experiments eluted between 21% and 23% buffer B.
Tandem Mass Spectrometric Measurements. Microcapillary col-
umns containing reverse-phase packing material were con-
structed as described (20). The column was equilibrated with
aqueous 0.2% acetic acid and 2% acetonitrile (solvent A) before
injecting the sample. Liquid chromatography was carried out at
400–600 nlmin by using a Magic 2002 capillary HPLC system
plumbed to a Magic Variable Splitter (Michrom BioResources,
Auburn, CA) or by using a Hewlett–Packard 1100 series HPLC
system. The column was coupled online with the mass spectrom-
eter using a PicoView nanospray ionization source (New Ob-
jective, Cambridge, MA) or as described (25). The peptides were
eluted with a gradient program of 0–80% solvent B (0.2%
aqueous acetic acid and 90% acetonitrile) in 90 min. In some
experiments, multidimensional protein identification technol-
ogy, in which the peptide mixture is separated by two liquid
chromatography steps, was used (25).
The peptides were eluted directly into the ThermoFinnigan
(San Jose, CA) LCQ ion trap mass spectrometer. The LCQ
heated capillary temperature was 190°C, and the spray voltage
was 1.2–2.4 kV. MSMS data were collected in an automatic
data-dependent scanning mode (isolation width, 3 mass to
charge ratio (mz); normalized collision energy, 35). The spec-
trometer collected cycles of four scans: one full scan (200–2,000
mz) and three subsequent MSMS scans. Collision-induced
dissociation (CID) was performed on the three most abundant
ions detected in the full scan. In some experiments, specific mz
values were selected, the ZoomScan mode was used, direct
sample infusion was used, or an Applied Biosystems QSTAR
Pulsar (quadrupole-time of flight) mass spectrometer was used.
Database Searches. The SEQUEST algorithm (distributed by
ThermoFinnigan) correlates experimentally obtained CID spec-
tra to the theoretical CID spectra of peptide sequences from a
specified database and assigns a cross-correlation (Xcorr) score
(26). A subset database, containing Spinacia oleracea entries, was
constructed by using the Database Manager Program in Thermo-
Finnigan’s BioTools software package for initial searches. This
subset database was extracted from the National Center for
Biotechnology Information (NCBI) nonredundant database
(www.ncbi.nlm.nih.gov). After initial identification using this
database, searches were then conducted against the complete
NCBI database.
The protein basic local alignment search tool (BLASTP) was
used to search the complete, nonredundant NCBI database for
CP43 sequences that contain APWLEPLR (27). The search gave
51 complete sequences for CP43. Alignment of the CP43 se-
quences was carried out by using Genetics Computer Group
software (WISCONSIN PACKAGE, Accelrys, San Diego; refs. 28
and 29).
Site-Directed Mutagenesis and Photoinhibition Studies. Site-directed
mutants were constructed and confirmed in the cyanobacterium,
Synechocystis sp. PCC 6803, and photoinhibition studies were
performed by methods previously described (11, 13).
Peptide Synthesis. Two peptides, APWLEPLR and APXLEPLR,
where X refers to kynurenine (Advanced ChemTech, Louisville,
KY), were chemically synthesized at the University of Minnesota
Microchemical Facility (Minneapolis). The general stepwise
Merrifield’s solid-phase method, adapted by Perkin–Elmer, was
used for synthesis on a Perkin–ElmerApplied Biosystems pep-
tide synthesizer (30).
Peptide Modeling. Molecular minimization and dynamics studies
were performed on the sequence ‘‘TMRFWDLRAPWLEPL-
RGPNGLDLS’’ by using the Discover and Charmm packages of
INSIGHT II (Version 98.0). The biopolymer module in INSIGHT II
was used to build the peptides. The N terminus was an uncharged
amino group, and the C terminus was modeled as NH(CH3).
From an extended structure, initial minimizations were per-
formed for the sequence by using the Amber force field in the
Discover package. Dynamics were then performed by using the
Charmm or the Amber force field to generate the random
structures used for the final energy minimization.
Results
MSMS. In the experiments presented here, a CP43 tryptic
peptide, APWLEPLR, was found to be posttranslationally mod-
ified. In Fig. 1A, a diagram of the predicted CID cleavage pattern
of the unmodified parent ion, APWLEPLR, is shown. The
subscripts on the b and y ions (31) indicate the number of amino
acid residues in that peptide fragment. For ions of the same
charge, the sequence of amino acids can be assigned from the y
ion series, and the b series provides complementary sequence
information. Posttranslational modification of a peptide leads to
changes in mz for the peptide fragments carrying the modifi-
cation. Low energy CID can also cause loss of carbon monoxide,
water, and ammonia from certain amino acid side chains (for
review, see ref. 32). In this paper, assignments of the PSII-
derived CID spectra are based on comparison to synthesized
peptides.
Synthesized Peptides. The CID spectrum in Fig. 2A was acquired
from the synthesized peptide, APWLEPLR. The 2 parent ion
had a mass to charge ratio of 491.5. In the tandem mass
spectrum, ions were observed at mz 175, 385, 514, 627, 813, and
910, which were assigned to the predicted y ions, y1, y3, y4, y5, y6,
and y7 (Fig. 1 A). Confirmatory b ions were observed at mz 169
(b2), 355 (b3), 468 (b4), 597 (b5), and 807 (b7). In addition, 2
product ions, y6
2 and y7
2 (Fig. 2 A) and other ions arising from
the loss of NH3 (not labeled) were assigned. Overall, the majority
of the expected b and y ion series (Fig. 1 A) was observed, except
that the y2 ion predicted at mz 288 and the b6 ion predicted at
mz 694 (Fig. 1 A) did not have significant intensity. The
predicted b1 ion at mz 72 was below the detection range.
The CID spectrum in Fig. 2B was obtained from the synthe-








sized peptide, APXLEPLR (Fig. 2B), where X indicates a
kynurenine at position 3. Kynurenine is 4 daltons, compared
with tryptophan (Fig. 1B). As expected, the 2 parent ion,
(M2H)2, had a mass to charge ratio of 493.3. Comparison of
the ions in Fig. 2 (A and B) shows that y1, y3, y4, and y5 have the
same mz values in each spectrum. However, the y6 and y7 ions,
which contain X, were 4 mz compared with the y6 and y7 ions
in Fig. 2 A. In addition, the b ions at mz 359 (b3), 472 (b4), 601
(b5), and 811 (b7) were4 mz compared with the b3, b4, b5, and
b7 ions in Fig. 2 A. The observed mz increments are consistent
with the replacement of tryptophan with kynurenine in the
synthesized peptide.
CP43-Derived Peptides. Fig. 2 C–F shows representative CID
spectra acquired from PSII peptides. These peptides were gen-
erated by an in gel tryptic digest of PSII-3. The CID spectrum
presented in Fig. 2C is similar to the CID spectrum obtained for
the synthesized peptide, APWLEPLR (Fig. 2 A). The 2 parent
ion (Fig. 2C) had a similar mass to charge ratio, 491.7 mz. Ions,
assignable to y1, y3–y6, b2–b5, and b7, had identical mz values in
the PSII peptide (Fig. 2C) and in the chemically synthesized
peptide (Fig. 2 A). Additional ions with the same mz values
include the 2 product ions, y6
2 and y7
2 (Fig. 2C), and ions
arising from the loss of NH3 (not labeled). Because of the
similarity of the spectra, we conclude that the PSII peptide,
giving rise to Fig. 2C, and the synthesized peptide, APWLEPLR
(Fig. 2 A), have the same sequence.
The CID spectrum presented in Fig. 2D was also acquired
from a PSII peptide. The spectrum is similar to the CID
spectrum obtained from the synthesized peptide, APXLEPLR
(Fig. 2B), where X is kynurenine. The 2 parent ion had a
similar mass to charge ratio, 493.5 mz (Fig. 2D). Comparison of
Fig. 2 B and D shows that the y1–y7, b2–b5, and b7 ions have the
same mz values in both spectra. An intense y7
2 ion was also
observed in both CID data sets (Fig. 2 B and D). These CID data
are consistent with a 4 posttranslational modification on
Trp-352 in CP43. We conclude that the PSII peptide giving rise
to Fig. 2D has the sequence, APW*LEPLR, where W* corre-
sponds to kynurenine (Fig. 1B). Kynurenine can be generated
posttranslationally from tryptophan through oxidative cleavage
of the indole ring (33).
The CID spectrum presented in Fig. 2E was derived from a2
parent ion at mz 499.2. The mass to charge ratio of the parent
ion and the tandem mass spectrum are consistent with an
assignment to APW*LEPLR, where W* has a mass of 16
compared with W. For example, in Fig. 2E, the unmodified
sequence, LEPLR, can be identified because ions, assignable to
y1, y2, y3, y4, and y5 (Fig. 1 A), were observed. However, the 813
(y6) mz ion in Fig. 2C was not observed in Fig. 2E, but an ion
with a similar intensity was observed at 829 mz. If the 829 ion
in Fig. 2E is assigned to y6, then the mz change is consistent with
16 modification of Trp-352. This interpretation is supported by
assignment of b3, b4, b5, and b6 ions at 371, 484, 613, and 712 mz
(Fig. 2E). These b ions are 16 compared with the b ion series
observed for the unmodified APWLEPLR peptide (Fig. 2C).
Two confirmatory2 ions, y6
2 and y7
2, were assigned (Fig. 2E).
In these ion trap experiments, low abundant fragment ions,
such as a putative y7 ion in Fig. 2E, may have mz values that
differ by 1 mz unit when compared with the theoretical
prediction. This is caused by poor ion statistics (34). Therefore,
to support the W16 assignment, high mass resolution CID
spectra were obtained from this PSII peptide by using a quad-
rupoletime-of-f light mass spectrometer (data not shown). The
mz values for the y3–y7 ions were measured with a mass accuracy
of 50 ppm, and these data support the assigned APW*LEPLR
sequence. For example, the y7 ion was observed with a mz of
926.489, which confirms the16 modification of the tryptophan.
A16 modification of tryptophan is consistent with the expected
mass for oxindolylalanine, the keto derivative of tryptophan,
which has been described (Fig. 1C) (35).
The CID spectrum presented in Fig. 2F was derived from a2
parent ion at mz 500.9. The mass to charge ratio of the parent
ion and the tandem mass spectrum are consistent with an
assignment to APW*LEPLR, where W* has a mass of 18
compared with W. For example, in Fig. 2F, the unmodified
sequence, LEPLR, can be identified because ions, assignable to
y1, y3, y4, and y5 (Fig. 1 A), were observed. However, the 813 (y6)
ion in Fig. 2C was not observed in Fig. 2F, but an ion with a
similar intensity was observed at 831 mz. If the 831 ion is
assigned to y6, then the mz change is consistent with 18
modification of Trp-352. This interpretation is supported by
assignment of b3, b4, and b5 ions at 373, 486, and 615 mz (Fig.
2F), which are 18 compared with the b ion series observed for
the unmodified peptide in Fig. 2C. A confirmatory y7
2 ion was
also assigned (Fig. 2F). The 18 derivative of tryptophan may
correspond to a dihydro, 3-hydroxyl indolylalanine (Fig. 1C).
Other possible structures with the same mass cannot be
excluded.
PSII Preparations. The presence or absence of hydrazines (15) had
no apparent influence on the CID results. For example, there
was no evidence for covalent binding of hydrazine to this tryptic
peptide. A similar set of Trp-352 modifications was detected in
oxygen-evolving PSII and in PSII-3 and was detected in illumi-
nated and in dark-maintained PSII and PSII-3. Analysis of
representative ion chromatograms suggests that all three mod-
ified peptides were at least as abundant as the unmodified
peptide.
The same modifications were detected in samples that had
been purified by SDSPAGE electrophoresis (in gel) and in
samples that had not been subjected to electrophoresis (in situ).
For in situ PSII, SEQUEST Xcorr scores ranged from 1.4 to 2.0.
Higher Xcorr scores were observed when samples were resus-
pended in formic acid, and specific ions were selected in the
scanning mode. This data acquisition scheme ensures that
modified peptides, which elute over a short time span in the
chromatogram, are detected. Taken together, these results imply
Fig. 1. Diagram showing the predicted, monoisotopic mz values for singly
charged b- and y-ions derived from the CP43 tryptic peptide, APWLEPLR (A),
the structure of kynurenine (W4) (B), and structures of the 16 and 18
tryptophan modifications (C).
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that CP43 posttranslational modifications are an intrinsic prop-
erty of PSII and are not induced by our handling procedures.
CP43 Sequence Alignment. An amino acid sequence alignment was
performed for 51 complete CP43 sequences in the nonredundant
database. Fig. 3A presents representative sequences for 15
species. The overall level of sequence identity for loop E was
60%. The A350PWLEPLR357 sequence (Synechocystis sp. PCC
6803) of CP43 was found to be very highly conserved. Trp-352
was conserved in all 51 species, except in Synechococcus PCC
Fig. 2. CIDmass spectraderivedfromthesynthesizedpeptide,APWLEPLR(A), fromthesynthesizedpeptide,APXLEPLR,whereXiskynurenine(B),andfromPSII tryptic
peptides (C–F). (C) The PSII spectrum is assigned to the tryptic CP43 peptide, APWLEPLR. (D–F) The PSII spectra are assigned to tryptic CP43 peptides derived by
posttranslational modification, APW*LEPLR, where the tryptophan mass shift is4 (D),16 (E), and18 (F). (A–F) The (M2H)2 parent ions had mz values of 491.5,
493.3, 491.7, 493.5, 499.2, and 500.9, respectively. Each PSII assignment (C–F) was the top choice when SEQUEST searches were performed against the nonredundant
database. The Xcorr scores were 2.5 (C), 2.4 (D), 2.4 (E), and 2.1 (F). For comparison, the CID spectrum in A, which was derived from the synthesized peptide, had an Xcorr
score of 2.2. For peaks with good ion statistics, the mass accuracy in these2,000 mz ion-trap experiments is 250–500 ppm.








7942, in which this position was assigned as a cysteine. Pro-355
was completely conserved in all CP43 sequences in the nonre-
dundant database. Pro-351 was also highly conserved in CP43
sequences (Fig. 3), with only one substitution in Heterocapsa,
whereas Pro-359 had three substitutions in Prochlorococcus,
Cyanophora, and Heterocapsa.
Site-Directed Mutagenesis. Previous work has shown that loop E
is important in the assembly or function of PSII (9, 11, 12, 36).
Two mutations, F345-E354 and W352-N360, deleted part of
the A350PWLEPLR357 sequence (9). The deletion mutant,
F345-E354, had wild-type levels of CP43 but was unable to
evolve oxygen or assemble functional PSII (9). The deletion
mutant, W352-N360, was unable to evolve oxygen or assemble
functional PSII (9). Also, the site-directed mutant, E354Q, lost
the capacity for photoautotrophic growth, contained no detect-
able CP43 protein, and was unable to evolve oxygen or assemble
functional PSII (11).
We have generated three site-directed mutations at Trp-352
(W352L, W352A, and W352C) in the Synechocystis CP43 sub-
unit. Our preliminary data show that in all three mutants, the
half-time for PSII photoinhibition decreases by the same factor
of 3–4, relative to wild-type cells. These experiments suggest that
the unmodified form of Trp-352 plays a role in the protection of
PSII from light-induced damage.
Modeling of the Peptide Sequence. The presence of three
highly conserved prolines in the protein sequence,
A350PWLEPLRGPN360, suggests a structural significance for
this region of loop E, which contains the posttranslationally
modified tryptophan. Fig. 3B shows the results of structural
modeling of the CP43 peptide, TMRFWDLRAPWLEPLRG-
PNGLDLS. A representative model from a family of lowest
energy conformations is presented. This peptide is not predicted
to form -helix or -sheet, but adopts a compact structure with
distinct turns at each proline. The turns imposed by the prolines
may position the tryptophan for modification. This model pre-
dicts that Trp-352 and the totally conserved Pro-355 are exposed
on the same face of the CP43 peptide. This result may be
consistent with surface exposure of Trp-352.
Discussion
These MSMS studies provide evidence for novel modifications
in the CP43 subunit of PSII. These data are consistent with three
Trp-352 modifications, which result in mass increases of 4,
16, and 18 daltons. Based on a comparison to a synthesized
peptide, the 4 tryptophan modification is assigned to kynure-
nine (Fig. 1B). Kynurenine has been identified previously in a
low density lipoprotein (37). In that protein, cleavage of the
indole ring is a metal-catalyzed oxidation reaction. Kynurenine
can also be generated by treatment of tryptophan-containing
peptides and proteins with hydrogen peroxide (35). The 16
modification is tentatively assigned to oxindolylalanine (Fig.
1C). This modification has also been reported (35). To our
knowledge, the 18 form of tryptophan has not been described
previously, but it is tentatively assigned to a hydroxylated indole
derivative of tryptophan (Fig. 1C).
Oxidative modifications to tryptophan are likely to be caused
by reactive oxygen species (38). These reactive species can be
produced as a byproduct of PSII water-splitting or in PSII centers
in which oxygen evolution is disrupted (39). We observe multiple
oxidative modifications of one tryptophan side chain. One
possible explanation of our results is that the oxindolylalanine
(16) and the hydroxyindole (18) derivatives are intermedi-
ates, which are produced during the oxidative cleavage of the
indole ring to give kynurenine as a final product (4).
Previous mutational studies support the conclusion that the
sequence APWLEPLR plays a structural or functional role in
PSII. Our own site-directed mutations at Trp-352 are also
consistent with this conclusion. Therefore, we propose that
posttranslational modification of this region is a key element in
PSII structure, function, turnover, or assembly. In our experi-
ments, both modified and unmodified AWPLEPR peptides were
detected. Therefore, it seems likely that the modifications are
transient or accumulated and that these modifications play a role
in signaling and not a stable role in structure.
Previously, a triggering mechanism has been proposed to be
important in signaling the turnover of PSII (see ref. 40 and
references therein). A conformational change is one possible
triggering mechanism (41). It has been proposed that covalent
modification of D1 may be involved in signaling for D1 turnover (41,
Fig. 3. Alignment of derived amino acid sequences for luminal loop E of the
CP43 subunit (A) and a structural model of the spinach CP43 sequence,
TMRFWDLRAPWLEPLRGPNGLDLS (B). (A) Representative CP43 sequences
from 15 species are presented. The species, listed in order of appearance, are
as follows (accession numbers are given in parentheses): Synechocystis sp. PCC
6803 (BAA17799), Anabaena sp. (L21857), Synechococcus sp. PCC 7942
(U30252), Secale cereale (S03436), Zea mays (S58537), Pisum sativum (P06004),
Nicotiana tabacum (P06413), Marchantia polymorpha (F2LV44), Spinacia ol-
eracea (7636084), Chlamydomonas reinhardtii (AB044528), Cyanophora
(AAA81279), Guillardia theta (NP050677), Euglena gracilis (S34498), Prochlo-
rococcus marinus (AAK69277), and Heterocapsa triquetra (AAD44702). The
Synechocystis 6803-aa numbering scheme was used; the first valine at the
alternate start site is amino acid no. 1 (7). (B) Trp-352, Pro-351, Pro-355, and
Pro-359 are indicated as wireframe.
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42). This is intriguing because oxidative modifications have been
implicated as the trigger of protein turnover in bacteria (43).
Therefore, we speculate that the accumulation of these oxi-
dative modifications in CP43 plays a role in the turnover of CP43,
D1, andor other PSII subunits. Structural modeling of
APWLEPLR may be consistent with exposure of Trp-352 on the
face of loop E. The formation of kynurenine may serve as a signal
for CP43 andor D1 processing through an interaction with a
luminal protease (for examples of identified luminal proteases,
see refs. 44 and 45). Roles in the assembly of the PSII reaction
center are also possible.
Previous studies of the turnover and repair of PSII have
focused mainly on turnover in vitro under illumination, referred
to as photoinhibition (for reviews, see refs. 40 and 46). During
photoinhibition, PSII is susceptible to illumination-induced
damage, and rapid turnover of PSII subunits can be detected.
Two different mechanisms have been proposed: an acceptor side
mechanism that occurs in oxygen-evolving PSII and a donor side
mechanism that occurs in manganese-depleted PSII (40, 46).
The D1 subunit exhibits rapid turnover in vivo (see ref. 47 and
references therein), and the turnover rate increases under pho-
toinhibitory conditions (reviewed in ref. 48). Other PSII sub-
units, such as D2 (49) and CP43 (50), are also proteolyzed during
photoinhibition. The proteolytic products produced from CP43
have not yet been characterized. Proteolysis of CP43 during
photoinhibition has been reported to require high light intensi-
ties, removal of the manganese-stabilizing protein, and loss of
manganese (51). Our site-directed mutagenesis experiments
show a connection between Trp-352 in CP43 and photoinhibi-
tory effects because all three substitutions at Trp-352 increased
the susceptibility of PSII to photodamage. These experiments
suggest that the unmodified indole side chain of Trp-352 plays a
role in the protection of PSII at high light intensities.
In summary, mass spectral analysis shows that CP43 can be
modified to give a kynurenine derivative of tryptophan. Inter-
mediates in the indole cleavage reaction have also been detected.
We hypothesize that these oxidative modifications are mediated
by reactive oxygen species and that the generation of kynurenine
in the CP43 sequence, APWLEPLR, signals the turnover of PSII
subunits.
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